Introduction to Pharmacovigilance (PV): Definition, History and Key Concepts for Beginners
Introduction
Pharmacovigilance (PV) is an essential discipline in healthcare that focuses on ensuring the safety of medicines. Since no drug is completely free from risk, continuous monitoring is required to detect and prevent adverse effects and to protect patients and public health.
This blog explains the basic concepts of Pharmacovigilance, including its definition, objectives, scope, types, and historical background. It is especially useful for students, freshers, and beginners in Pharmacovigilance.
What is Pharmacovigilance?
- Pharmacovigilance is a medical profession and scientific discipline that involves activities aimed at promoting and safeguarding patient safety and public health.
- According to the World Health Organization (WHO), Pharmacovigilance is the science and activities related to the detection, assessment, understanding, and prevention of adverse events or any other drug-related problems.
- In routine pharmacovigilance practice, safety data are primarily managed through Individual Case Safety Reports (ICSRs). To understand how case handling works step-by-step, read our detailed guide on ICSR processing in pharmacovigilance.
Objectives and Scope of Pharmacovigilance
Pharmacovigilance involves:
- Studying the causal relationship between an administered drug and an observed adverse event
- Detecting, assessing, and preventing adverse drug reactions (ADRs). A clear understanding of the types of adverse drug reactions is essential for accurate drug safety monitoring.
- Promoting safe and rational use of medicines
- Safeguarding public health related to medication use
- Creating awareness among: Patients, General public, Healthcare professionals (HCPs)
- Evaluating the benefit–risk profile of drugs throughout their lifecycle.
- During case assessment, professionals must also clearly understand the difference between seriousness and severity in pharmacovigilance, as both impact regulatory reporting decisions.
Meaning and Origin of the Term Pharmacovigilance
The word Pharmacovigilance is derived from two languages:
- Pharmakon (Greek) – meaning Drug
- Vigilare (Latin) – meaning To watch or monitor
This indicates that medicines must always be monitored, as they can cause adverse events at any time and are not completely safe under all circumstances.
When Does Pharmacovigilance Start?
Pharmacovigilance begins from the day an Investigational New Drug (IND) is first tested in human clinical trials and continues throughout clinical development, post-marketing surveillance, until the drug is withdrawn from the market.
Pharmacovigilance is not applicable to pre-clinical animal studies, because animals cannot report adverse events. However, animal toxicity data may be used as a reference for assessing safety in humans. As per ICH guidelines (ICH E2A–E2F), Pharmacovigilance applies only to human studies.
The History of Pharmacovigilance: From Tragedy to Global Safety
1. Early Origins: Disasters That Shaped PV (1800s–1960s)
1848 — Chloroform Death: Hannah Greener, a 15-year-old girl, died during toenail surgery under chloroform anesthesia. This highlighted that even widely used drugs could have fatal outcomes.
1937 — Sulfanilamide Elixir Disaster (U.S.): Over 100 deaths, mostly children, due to a toxic solvent (diethylene glycol) in liquid sulfanilamide. This led to the U.S. Federal Food, Drug, and Cosmetic Act (1938).
1961 — Thalidomide Tragedy (Europe): ~10,000 infants born with limb deformities due to maternal thalidomide use. This was the catalyst for modern pharmacovigilance.
2. Global Movement & Institutionalization
- 1963–1968: WHO adopted a resolution for the systematic collection of serious ADRs.
- 1968: WHO Programme for International Drug Monitoring (PIDM) established.
- 1971–1978: Uppsala Monitoring Centre (UMC) established in Sweden; manages VigiBase.
- 1964: Yellow Card Scheme (UK) — First national ADR reporting system.
- 1995: EMA established for EU-wide coordination of PV activities.
- 2010: Pharmacovigilance Programme of India (PvPI) launched under CDSCO.
Types of Pharmacovigilance (PV)
1. Passive Pharmacovigilance (Spontaneous Reporting)
Definition: Passive PV is when suspected adverse events are voluntarily reported by healthcare professionals (HCPs) or patients to the MAH, Regulatory Authority, or National PV Coordination Centre (NPVCC). Also called Spontaneous Reporting or Unsolicited Reporting.
Advantages: Simple and cost-effective. Good for detecting rare or serious ADRs.
Limitations: Often under-reported. Reports may lack details needed for assessing causality.
2. Active Pharmacovigilance (Active Surveillance)
Definition: Active PV is a proactive and systematic collection of adverse event data by MAHs. Also called Solicited Reporting.
Advantages: Provides accurate incidence and risk data. Helps identify trends and safety signals.
Limitations: Requires resources and planning. More time-consuming than passive PV.
According to WHO, passive PV is the cornerstone of routine pharmacovigilance, while active PV ensures high-quality and complete data collection. Both work together: passive PV generates safety signals, and active PV validates and quantifies risks.
Frequently Asked Questions (FAQs)
Q1: What is pharmacovigilance?
Pharmacovigilance (PV) is the science of monitoring the safety of medicines and detecting, assessing, and preventing adverse drug reactions (ADRs) to protect patients.
Q2: Why is pharmacovigilance important?
It ensures medicines are safe for patients by identifying side effects, reducing risks, and improving patient safety.
Q3: What is an adverse drug reaction (ADR)?
An ADR is an unwanted or harmful effect experienced after taking a medicine at normal doses.
Q4: What are the main objectives of pharmacovigilance?
Detect adverse drug reactions, ensure patient safety, monitor drug risk–benefit balance, and promote safe use of medicines.
Q5: Who reports adverse drug reactions?
Doctors, pharmacists, nurses, patients, and pharmaceutical companies.
Q6: Can freshers build a career in pharmacovigilance?
Yes. Many freshers from pharmacy and life-science backgrounds start with roles like Drug Safety Associate or PV Associate.
Comments
Post a Comment